Nasopharyngeal Carcinoma
458
87
121
103
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
14 trials with published results (3%)
Research Maturity
103 completed trials (22% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
4.4%
20 terminated out of 458 trials
83.7%
-2.8% vs benchmark
22%
102 trials in Phase 3/4
14%
14 of 103 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 103 completed trials
Clinical Trials (458)
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Proton Versus Photon Radiotherapy for Nasopharyngeal Carcinoma
Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)
Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma
Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer
Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
Optimization of Cervical Nodal CTV for Early and Medium Stage NPC
Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
CD70-targeted immunoPET Imaging of Malignant Cancers
Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition
Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC